297 related articles for article (PubMed ID: 16280854)
1. The effects of botulinum-A toxin on bladder function and histology in spinal cord injured rats: is there any difference between early and late application?
Temeltas G; Tikiz C; Dagci T; Tuglu I; Yavasoglu A
J Urol; 2005 Dec; 174(6):2393-6. PubMed ID: 16280854
[TBL] [Abstract][Full Text] [Related]
2. In vivo effects of botulinum toxin A on visceral sensory function in chronic spinal cord-injured rats.
Khera M; Somogyi GT; Salas NA; Kiss S; Boone TB; Smith CP
Urology; 2005 Jul; 66(1):208-12. PubMed ID: 15992889
[TBL] [Abstract][Full Text] [Related]
3. Evidence of a peripheral role of neurokinins in detrusor hyperreflexia: a further study of selective tachykinin antagonists in chronic spinal injured rats.
Abdel-Gawad M; Dion SB; Elhilali MM
J Urol; 2001 May; 165(5):1739-44. PubMed ID: 11342967
[TBL] [Abstract][Full Text] [Related]
4. Intrathecal or dietary glycine inhibits bladder and urethral activity in rats with spinal cord injury.
Miyazato M; Sugaya K; Nishijima S; Kadekawa K; Ashimine S; Ogawa Y
J Urol; 2005 Dec; 174(6):2397-400. PubMed ID: 16280855
[TBL] [Abstract][Full Text] [Related]
5. Repeated botulinum-A toxin injections in the treatment of myelodysplastic children and patients with spinal cord injuries with neurogenic bladder dysfunction.
Akbar M; Abel R; Seyler TM; Bedke J; Haferkamp A; Gerner HJ; Möhring K
BJU Int; 2007 Sep; 100(3):639-45. PubMed ID: 17532858
[TBL] [Abstract][Full Text] [Related]
6. Botulinum toxin A inhibits ATP release from bladder urothelium after chronic spinal cord injury.
Khera M; Somogyi GT; Kiss S; Boone TB; Smith CP
Neurochem Int; 2004 Dec; 45(7):987-93. PubMed ID: 15337297
[TBL] [Abstract][Full Text] [Related]
7. Central inhibitory effect of intravesically applied botulinum toxin A in chronic spinal cord injury.
Munoz A; Somogyi GT; Boone TB; Smith CP
Neurourol Urodyn; 2011 Sep; 30(7):1376-81. PubMed ID: 21509809
[TBL] [Abstract][Full Text] [Related]
8. Botulinum toxin type a is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study.
Schurch B; de Sèze M; Denys P; Chartier-Kastler E; Haab F; Everaert K; Plante P; Perrouin-Verbe B; Kumar C; Fraczek S; Brin MF;
J Urol; 2005 Jul; 174(1):196-200. PubMed ID: 15947626
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of intravesically applied botulinum toxin A in chronic bladder inflammation.
Vemulakonda VM; Somogyi GT; Kiss S; Salas NA; Boone TB; Smith CP
J Urol; 2005 Feb; 173(2):621-4. PubMed ID: 15643276
[TBL] [Abstract][Full Text] [Related]
10. Botulinum toxin type A inhibits sensory neuropeptide release in rat bladder models of acute injury and chronic inflammation.
Lucioni A; Bales GT; Lotan TL; McGehee DS; Cook SP; Rapp DE
BJU Int; 2008 Feb; 101(3):366-70. PubMed ID: 18184328
[TBL] [Abstract][Full Text] [Related]
11. Effects of ZD6169 and ZD0947, 2 potassium adenosine triphosphate channel openers, on bladder function of spinalized rats.
Abdel-Karim AM; Bialecki RA; Elhilali MM
J Urol; 2002 Aug; 168(2):837-42. PubMed ID: 12131377
[TBL] [Abstract][Full Text] [Related]
12. Effect of botulinum toxin on detrusor overactivity induced by intravesical adenosine triphosphate and capsaicin in a rat model.
Atiemo H; Wynes J; Chuo J; Nipkow L; Sklar GN; Chai TC
Urology; 2005 Mar; 65(3):622-6. PubMed ID: 15780404
[TBL] [Abstract][Full Text] [Related]
13. Botulinum-A toxin injections into the detrusor muscle decrease nerve growth factor bladder tissue levels in patients with neurogenic detrusor overactivity.
Giannantoni A; Di Stasi SM; Nardicchi V; Zucchi A; Macchioni L; Bini V; Goracci G; Porena M
J Urol; 2006 Jun; 175(6):2341-4. PubMed ID: 16697870
[TBL] [Abstract][Full Text] [Related]
14. Bladder function recovery in rats with traumatic spinal cord injury after transplantation of neuronal-glial restricted precursors or bone marrow stromal cells.
Temeltas G; Dagci T; Kurt F; Evren V; Tuglu I
J Urol; 2009 Jun; 181(6):2774-9. PubMed ID: 19375728
[TBL] [Abstract][Full Text] [Related]
15. Apoptotic action of botulinum toxin on detrusor muscle in rats.
Watanabe T; Masago T; Miyagawa I
Urol Int; 2010; 84(3):341-6. PubMed ID: 20389167
[TBL] [Abstract][Full Text] [Related]
16. Botulinum toxin type A injections for treating neurogenic detrusor overactivity combined with low-compliance bladder in patients with spinal cord lesions.
Klaphajone J; Kitisomprayoonkul W; Sriplakit S
Arch Phys Med Rehabil; 2005 Nov; 86(11):2114-8. PubMed ID: 16271557
[TBL] [Abstract][Full Text] [Related]
17. Botulinum toxin A detrusor injections in patients with neurogenic detrusor overactivity significantly decrease the incidence of symptomatic urinary tract infections.
Gamé X; Castel-Lacanal E; Bentaleb Y; Thiry-Escudié I; De Boissezon X; Malavaud B; Marque P; Rischmann P
Eur Urol; 2008 Mar; 53(3):613-8. PubMed ID: 17804150
[TBL] [Abstract][Full Text] [Related]
18. Increased efficacy and decreased systemic-effects of botulinum toxin A injection after active or passive muscle manipulation.
Minamoto VB; Hulst JB; Lim M; Peace WJ; Bremner SN; Ward SR; Lieber RL
Dev Med Child Neurol; 2007 Dec; 49(12):907-14. PubMed ID: 18039237
[TBL] [Abstract][Full Text] [Related]
19. [Experimental study on morphological changes of detrusor muscle and its neuromuscular junction after medullary cone injury in rats].
Hou C; Zheng X; Chen A
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2007 May; 21(5):473-7. PubMed ID: 17578285
[TBL] [Abstract][Full Text] [Related]
20. Passive biaxial mechanical properties of the rat bladder wall after spinal cord injury.
Gloeckner DC; Sacks MS; Fraser MO; Somogyi GT; de Groat WC; Chancellor MB
J Urol; 2002 May; 167(5):2247-52. PubMed ID: 11956487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
